ERVW-1 and cancer: In this regard, several studies have been carried out to evaluate the immunogenic responses of patients with tumors and cancers against HERV-K immunogens, such as Gag, Pol, Env, and reverse transcriptase inhibitors, etc. Some of the therapies against HERV-K-induced tumors and cancers are as follows: